Several other prognostic models for NSCLC have been developed based on biomarkers related to inflammation and/or nutritional status, including peripheral blood cell count parameters, CRP, albumin, and BMI, such as the Prognostic Nutritional Index, the Advanced Lung Cancer Inflammation Index, and the Glasgow prognostic score [47,48,49]. This evidence concerns the gene ALB and lung cancer.